Grant: Doctoral: Vanier Canada Graduate Scholarships
McGill University
$150,000.00
Mechanisms of inhibitory neurotransmission related to remission from symptoms of multiple sclerosis
EF 2013-14
Résumé
Multiple Sclerosis (MS) affects over 50,000 people in Canada, often striking in early adulthood. Despite the persistence of diffuse brain damage caused by this disease, the associated motor, cognitive, sensory, and psychiatric symptoms often greatly improve during spontaneous remission phases. Although the mechanism mediating remission from MS symptoms is unknown, it is hypothesized that inhibitory neurotransmission lessens the severity of symptoms by mitigating the negative effects of neuroinflammation, excitotoxic neurotransmission, and physical brain damage. Thus, biomarkers of these disease-mediating components should in combination predict the extent of remission from symptoms. Forty patients with MS and 30 age and sex matched healthy controls will participate in this multi-part study, including (1) Advanced neuroimaging methods to measure white and grey matter damage, (2) Magnetic resonance spectroscopy to measure biomarkers of neuroinflammation and excitatory neurotransmitter concentrations, (3) Transcranial magnetic stimulation paradigms optimized to assess excitatory and inhibitory neurotransmission, and (4) Clinical and demographic data collection. Differences in the relationship between these variables will be compared between patients of various levels of symptom severity as well as healthy participants. Furthermore, the design of this study will allow for follow-up projects, which will assess the prognostic value of combining information from these biomarkers. This project will make a novel contribution to understanding neurophysiological processes that lessen symptom severity in MS. Such findings could lead to useful tools for diagnostic and prognostic procedures. Furthermore, this project will help researchers and clinicians identify compensatory neurophysiological mechanisms that could be exploited for new therapeutic strategies to mitigate relapse occurrence and disease progression.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
299885
Name
Nantes Julia C
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Mechanisms of inhibitory neurotransmission related to remission from symptoms of multiple sclerosis
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Multiple Sclerosis; Neurophysiology; Neurorehabilitation; Neuroscience
Abstract
Multiple Sclerosis (MS) affects over 50,000 people in Canada, often striking in early adulthood. Despite the persistence of diffuse brain damage caused by this disease, the associated motor, cognitive, sensory, and psychiatric symptoms often greatly improve during spontaneous remission phases. Although the mechanism mediating remission from MS symptoms is unknown, it is hypothesized that inhibitory neurotransmission lessens the severity of symptoms by mitigating the negative effects of neuroinflammation, excitotoxic neurotransmission, and physical brain damage. Thus, biomarkers of these disease-mediating components should in combination predict the extent of remission from symptoms. Forty patients with MS and 30 age and sex matched healthy controls will participate in this multi-part study, including (1) Advanced neuroimaging methods to measure white and grey matter damage, (2) Magnetic resonance spectroscopy to measure biomarkers of neuroinflammation and excitatory neurotransmitter concentrations, (3) Transcranial magnetic stimulation paradigms optimized to assess excitatory and inhibitory neurotransmission, and (4) Clinical and demographic data collection. Differences in the relationship between these variables will be compared between patients of various levels of symptom severity as well as healthy participants. Furthermore, the design of this study will allow for follow-up projects, which will assess the prognostic value of combining information from these biomarkers. This project will make a novel contribution to understanding neurophysiological processes that lessen symptom severity in MS. Such findings could lead to useful tools for diagnostic and prognostic procedures. Furthermore, this project will help researchers and clinicians identify compensatory neurophysiological mechanisms that could be exploited for new therapeutic strategies to mitigate relapse occurrence and disease progression.
Competitiondate
201311
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Nantes, Julia C
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~